Evaluate the efficacy and safety of the drug. In turn, the clinical phase is divided into four phases: phase i, ii, iii and iv. Phases i, ii, iii and iv: phase i is carried out in a small group of healthy volunteers to demonstrate the safety of the drug. Phase ii is carried out in a larger sample of patients with the disease in question to re-evaluate safety and efficacy at the optimal therapeutic dose. Phase iii is carried out in a larger sample (>1,000 patients) to evaluate the efficacy and safety of the drug with the indications approved in the previous phases and in
comparison with other standard treatments or placebos. 4) approval, registration and commercialization phase. Once all the checks described above have been completed, all the reports of the trials carried out are sent to request the registration and approval whatsapp number list of the drug for marketing by the regulatory authorities. The medical affairs. What are we talking about? Classically, in a pharmaceutical company, a sales representative performed both medical and commercial functions. This trend is already changing due to the need for companies to have professionals not only with communication and organizational skills but also with scientific knowledge.
This is so because both marketing strategies and scientific knowledge play a decisive role in the development of a brand and in the success of sales in such a competitive market. Broadly speaking, when we talk about medical affairs , we are referring to the environment of the medical department in a pharmaceutical industry, a biotechnology company or any company in the health sector. The function of a medical affairs in biotechnology consists of training and informing about the most relevant aspects of the medicine or any other biotechnological product. Competencies and skills of a medical affairs: